Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians
- PMID: 18990739
- PMCID: PMC2772063
- DOI: 10.1158/1055-9965.EPI-07-2879
Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians
Abstract
The increasing availability and public awareness of BRCA1/2 genetic testing will increase women's self-referrals to genetic services. The objective of this study was to examine whether patient characteristics influence the referral decisions of family physicians when a patient requests BRCA1/2 genetic testing. Family physicians (n = 284) completed a Web-based survey in 2006 to assess their attitudes and practices related to the use of genetics in their clinical practice. Using a 2 x 2 x 2 factorial design, we tested the effects of a hypothetical patient's race, level of worry, and insurance status on the decisions of family physicians to refer her for BRCA1/2 testing. The patient was not appropriate for referral based on U.S. Preventive Services Task Force guidelines. No patient characteristics were associated with the family physicians' referral decisions. Although referral was not indicated, only 8% did not refer to genetic services; 92% referred for genetic services, and 50% referred to genetic counseling. Family physicians regarded it unlikely that the patient carried a mutation, but 65% of family physicians believed that if they refused to refer for genetic services it would harm their relationship with the patient. Despite scarce and costly genetic services, family physicians were likely to inappropriately refer a low-risk patient who requested BRCA1/2 testing. The implications of this inappropriate referral on women's screening behavior, genetic services, and health care costs are unknown. Clinicians and patients could benefit from education about the appropriate use of genetic services so that both are more comfortable with a decision against referral.
Figures
Comment in
-
Genetic services have value beyond BRCA1/2 testing.Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):686. doi: 10.1158/1055-9965.EPI-08-1087. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19208665 No abstract available.
Similar articles
-
Genetic services have value beyond BRCA1/2 testing.Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):686. doi: 10.1158/1055-9965.EPI-08-1087. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19208665 No abstract available.
-
Family physicians and referrals of low-risk women for BRCA1/2 genetic services.CA Cancer J Clin. 2009 Mar-Apr;59(2):70-2. doi: 10.3322/caac.20016. Epub 2009 Mar 3. CA Cancer J Clin. 2009. PMID: 19258448 No abstract available.
-
Dental screening and referral of young children by pediatric primary care providers.Pediatrics. 2004 Nov;114(5):e642-52. doi: 10.1542/peds.2004-1269. Pediatrics. 2004. PMID: 15520094
-
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.Ann Intern Med. 2014 Feb 18;160(4):255-66. doi: 10.7326/M13-1684. Ann Intern Med. 2014. PMID: 24366442 Review.
-
Variation in GP referral rates: what can we learn from the literature?Fam Pract. 2000 Dec;17(6):462-71. doi: 10.1093/fampra/17.6.462. Fam Pract. 2000. PMID: 11120716 Review.
Cited by
-
Digital innovation for cancer risk assessment allows large-scale service redevelopment of regional cancer genetics service delivery.Fam Cancer. 2024 Nov;23(4):591-598. doi: 10.1007/s10689-024-00407-x. Epub 2024 Jul 1. Fam Cancer. 2024. PMID: 38954285 Free PMC article.
-
Phenotype-Driven Molecular Genetic Test Recommendation for Diagnosing Pediatric Rare Disorders.Res Sq [Preprint]. 2023 Nov 22:rs.3.rs-3593490. doi: 10.21203/rs.3.rs-3593490/v1. Res Sq. 2023. PMID: 38045411 Free PMC article. Preprint.
-
BRCA testing in unaffected young women in the United States, 2006-2017.Cancer. 2020 Jan 15;126(2):337-343. doi: 10.1002/cncr.32536. Epub 2019 Sep 30. Cancer. 2020. PMID: 31568561 Free PMC article.
-
A theory-informed systematic review of clinicians' genetic testing practices.Eur J Hum Genet. 2018 Oct;26(10):1401-1416. doi: 10.1038/s41431-018-0190-7. Epub 2018 Jun 11. Eur J Hum Genet. 2018. PMID: 29891880 Free PMC article.
-
Physicians' Awareness and Utilization of Genetic Services in Texas.J Genet Couns. 2018 Aug;27(4):968-977. doi: 10.1007/s10897-017-0199-z. Epub 2017 Dec 26. J Genet Couns. 2018. PMID: 29280038
References
-
- Guttmacher AE, Collins FS. Realizing the promise of genomics in biomedical research. JAMA. 2005;294:1399–1402. - PubMed
-
- McClain MR, Palomaki GE, Nathanson KL, Haddow JE. Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: Public health implication. Genet Med. 2005;7:28–33. - PubMed
-
- Nelson HD, Huffman LH, Fu R, Harris EL. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2005;143:362–79. - PubMed
-
- Davis S, Stewart S, Bloom J. Increasing the accuracy of perceived breast cancer risk: Results from a randomized trial with Cancer Information Service caller. Prev Med. 2004;39:64–73. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
